Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Cell wall proteinaceous components in isolates of Candida albicans and non-albicans species from HIV-infected patients with oropharyngeal candidiasis.

López-Ribot JL, Kirkpatrick WR, McAtee RK, Revankar SG, Patterson TF.

Rev Iberoam Micol. 1998 Sep;15(3):125-30.

2.

Combination therapy with terbinafine and amphotericin B in a rabbit model of experimental invasive aspergillosis.

Kirkpatrick WR, Vallor AC, McAtee RK, Ryder NS, Fothergill AW, Rinaldi MG, Patterson TF.

Antimicrob Agents Chemother. 2005 Nov;49(11):4751-3.

3.

Comparison of DNA-based typing methods to assess genetic diversity and relatedness among Candida albicans clinical isolates.

López-Ribot JL, McAtee RK, Kirkpatrick WR, Perea S, Patterson TF.

Rev Iberoam Micol. 2000 Jun;17(2):49-54.

4.

Proteinase detection, DNA typing and antimycotic susceptibility of Candida isolates from Colombian women with vulvovaginal candidiasis.

Cardona-Castro N, Revankar SG, Ortiz P, Cuervo C, Kirkpatrick WR, McAtee RK, Patterson TF.

Rev Iberoam Micol. 2002 Jun;19(2):89-94.

5.

Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.

Perea S, López-Ribot JL, Kirkpatrick WR, McAtee RK, Santillán RA, Martínez M, Calabrese D, Sanglard D, Patterson TF.

Antimicrob Agents Chemother. 2001 Oct;45(10):2676-84.

6.

Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.

Kirkpatrick WR, McAtee RK, Fothergill AW, Rinaldi MG, Patterson TF.

Antimicrob Agents Chemother. 2000 Oct;44(10):2865-8.

7.

Efficacy of SCH56592 in a rabbit model of invasive aspergillosis.

Kirkpatrick WR, McAtee RK, Fothergill AW, Loebenberg D, Rinaldi MG, Patterson TF.

Antimicrob Agents Chemother. 2000 Mar;44(3):780-2.

8.

Growth competition between Candida dubliniensis and Candida albicans under broth and biofilm growing conditions.

Kirkpatrick WR, Lopez-Ribot JL, McAtee RK, Patterson TF.

J Clin Microbiol. 2000 Feb;38(2):902-4.

9.

Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer.

Redding SW, Zellars RC, Kirkpatrick WR, McAtee RK, Caceres MA, Fothergill AW, Lopez-Ribot JL, Bailey CW, Rinaldi MG, Patterson TF.

J Clin Microbiol. 1999 Dec;37(12):3896-900.

10.
11.

Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients.

Lopez-Ribot JL, McAtee RK, Perea S, Kirkpatrick WR, Rinaldi MG, Patterson TF.

Antimicrob Agents Chemother. 1999 Jul;43(7):1621-30.

12.
13.

Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.

Kirkpatrick WR, Revankar SG, Mcatee RK, Lopez-Ribot JL, Fothergill AW, McCarthy DI, Sanche SE, Cantu RA, Rinaldi MG, Patterson TF.

J Clin Microbiol. 1998 Oct;36(10):3007-12.

14.

A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance.

Revankar SG, Kirkpatrick WR, McAtee RK, Dib OP, Fothergill AW, Redding SW, Rinaldi MG, Hilsenbeck SG, Patterson TF.

Am J Med. 1998 Jul;105(1):7-11.

PMID:
9688014
15.

Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients.

Revankar SG, Dib OP, Kirkpatrick WR, McAtee RK, Fothergill AW, Rinaldi MG, Redding SW, Patterson TF.

Clin Infect Dis. 1998 Apr;26(4):960-3.

PMID:
9564483
16.
17.

Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method.

Revankar SG, Kirkpatrick WR, McAtee RK, Fothergill AW, Redding SW, Rinaldi MG, Patterson TF.

J Clin Microbiol. 1998 Jan;36(1):153-6.

18.

Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans.

Patterson TF, Kirkpatrick WR, Revankar SG, McAtee RK, Fothergill AW, McCarthy DI, Rinaldi MG.

J Clin Microbiol. 1996 Dec;34(12):3237-9.

19.

Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients.

Revankar SG, Kirkpatrick WR, McAtee RK, Dib OP, Fothergill AW, Redding SW, Rinaldi MG, Patterson TF.

J Infect Dis. 1996 Oct;174(4):821-7.

PMID:
8843222

Supplemental Content

Loading ...
Support Center